Baird is out defending Incyte (INCY -1.9%) today after the company announced the departure of...


Baird is out defending Incyte (INCY -1.9%) today after the company announced the departure of its Chief Commercial Officer yesterday. The firm notes that while being less than a year into its first product launch may not the ideal time for a change, it's comfortable that it isn't any performance-related issue, and the company can manage the transition with minimal disruption. INCY management says the move has nothing to do with the launch trajectory - which is most important to investors.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs